As of August 28, 2026, Drugs Made In America Acquisition Corp. (DMAA) has a DilutionWatch DilutionScore of 65/100, rated HIGH dilution risk. This is a component-limited score because one or more material inputs are unavailable or not applicable. Drugs Made In America Acquisition Corp. has a market capitalization of $257.58M, 24.28M shares outstanding, 39 institutional holders tracked.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Score Breakdown
📊Float Risk—
Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
model est. 30%
💰 Capital Raise
model 55%
• Critical: only 0.5 months cash remaining
📉 Score Deterioration
model 10%
• Score in HIGH risk zone (65/100)
Market Data
Market Cap$257.58M
Shares Outstanding24.28M
FloatN/A
Cash$20.3K
DebtN/A
Short InterestN/A
Institutional Holdings
QoQ: ↓ 9.5% shares (2026Q1 vs prior)
39 institutional holders · 24.31M shares
#1
Karpus Management, Inc.
2.53M shares
#2
First Trust Capital Management L.P.
2.24M shares
#3
MIZUHO SECURITIES USA LLC
2.00M shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest88.7K
Days to Cover5.1
% of FloatN/A
FINRA data as of Jul 31, 2026
Recent SEC Activity
8-K
8K EVENT
2026-05-01
8-K
8K EVENT
2026-04-28
8-K
8K EVENT
2026-03-27
Full SEC filing analysis available with free account
→
Recent News
No recent news
Factual DMAA Dilution Snapshot
Drugs Made In America Acquisition Corp. (DMAA) has a DilutionScore of 65/100, rated High dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for DMAA: 8-K on 2026-05-01; 8-K on 2026-04-28; 8-K on 2026-03-27.
- Score coverage note: Float Risk is excluded because public-float data is unavailable.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Track DMAA Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking DMAA — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
Score Coverage Note
- Float Risk is excluded because public-float data is unavailable.
More Research for DMAA
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.